Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota after lung transplant.
暂无分享,去创建一个
Kyle Bittinger | Emily S. Charlson | Frederic D Bushman | Anjana Yadav | Andrew R Haas | F. Bushman | K. Bittinger | R. Collman | A. Haas | J. Diamond | Joshua M Diamond | Ronald G Collman | Ayannah S Fitzgerald | Anjana Yadav | Emily S Charlson | Ayannah S. Fitzgerald
[1] R. Knight,et al. Bacterial Community Variation in Human Body Habitats Across Space and Time , 2009, Science.
[2] P. Corris,et al. Targeting Allograft Injury and Inflammation in the Management of Post‐Lung Transplant Bronchiolitis Obliterans Syndrome , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[3] J. Maurer. Respiratory Viral Infections Are a Distinct Risk for Bronchiolitis Obliterans Syndrome and Death , 2006 .
[4] P. Dartevelle,et al. Impairment of bronchial mucociliary clearance in long-term survivors of heart/lung and double-lung transplantation. The Paris-Sud Lung Transplant Group. , 1993, Chest.
[5] Robert K. Colwell,et al. A new statistical approach for assessing similarity of species composition with incidence and abundance data , 2004 .
[6] Paramvir S. Dehal,et al. FastTree 2 – Approximately Maximum-Likelihood Trees for Large Alignments , 2010, PloS one.
[7] J. Gower. Generalized procrustes analysis , 1975 .
[8] M. Dietrich,et al. Patterns of Mycobacterium avium Culture and PCR Positivity in Immunodeficient HIV-infected Patients: Progression from Localized to Systemic Disease , 1997 .
[9] Eoin L. Brodie,et al. Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa. , 2010, Environmental microbiology.
[10] R. Cattell,et al. The Procrustes Program: Producing direct rotation to test a hypothesized factor structure. , 2007 .
[11] Patrick M. Gillevet,et al. Characterization of the Oral Fungal Microbiome (Mycobiome) in Healthy Individuals , 2010, PLoS pathogens.
[12] Fang Liu,et al. Molecular analysis of the diversity of vaginal microbiota associated with bacterial vaginosis , 2010, BMC Genomics.
[13] B. Haas,et al. Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. , 2011, Genome research.
[14] N. Pace,et al. Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis , 2007, Proceedings of the National Academy of Sciences.
[15] H. Monteil,et al. Peripartum Bacteremias Due to Leptotrichia amnionii and Sneathia sanguinegens, Rare Causes of Fever during and after Delivery , 2004, Journal of Clinical Microbiology.
[16] G. Snell,et al. Chlamydia pneumoniae Serology in Donors and Recipients and the Risk of Bronchiolitis Obliterans Syndrome after Lung Transplantation , 2005, Transplantation.
[17] Vanja Klepac-Ceraj,et al. Comparative Analyses of the Bacterial Microbiota of the Human Nostril and Oropharynx , 2010, mBio.
[18] G. Verleden,et al. A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation , 2010, European Respiratory Journal.
[19] J. Orens,et al. Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study. , 2003, American journal of respiratory and critical care medicine.
[20] D. Schwartz,et al. Genetic Regulation of Rejection and Survival Following Human Lung Transplantation by the Innate Immune Receptor CD14 , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[21] Eoin L. Brodie,et al. Airway Microbiota and Pathogen Abundance in Age-Stratified Cystic Fibrosis Patients , 2010, PloS one.
[22] P. Jaccard. THE DISTRIBUTION OF THE FLORA IN THE ALPINE ZONE.1 , 1912 .
[23] Eoin L. Brodie,et al. Loss of Bacterial Diversity during Antibiotic Treatment of Intubated Patients Colonized with Pseudomonas aeruginosa , 2006, Journal of Clinical Microbiology.
[24] A. Rahmel,et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart-lung transplant report--2010. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[25] J. Curtis,et al. Analysis of the Lung Microbiome in the “Healthy” Smoker and in COPD , 2011, PloS one.
[26] G. Darling,et al. Bile acid aspiration and the development of bronchiolitis obliterans after lung transplantation. , 2005, The Journal of thoracic and cardiovascular surgery.
[27] V. Karthaus,et al. Polymorphisms in innate immunity genes associated with development of bronchiolitis obliterans after lung transplantation. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[28] R. Lowry,et al. The cough response to ultrasonically nebulized distilled water in heart-lung transplantation patients. , 1989, The American review of respiratory disease.
[29] A. Rahmel,et al. The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Lung and Heart-Lung Transplant Report--2011. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[30] David Artis,et al. Metagenomic analyses reveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasis , 2009, Mucosal Immunology.
[31] D. Schwartz,et al. Innate immunity influences long-term outcomes after human lung transplant. , 2005, American journal of respiratory and critical care medicine.
[32] B S Weir,et al. Estimating F-statistics. , 2002, Annual review of genetics.
[33] Hongzhe Li,et al. Disordered Microbial Communities In The Upper Respiratory Tract Of Cigarette Smokers , 2011, ATS 2011.
[34] Kyle Bittinger,et al. Topographical continuity of bacterial populations in the healthy human respiratory tract. , 2011, American journal of respiratory and critical care medicine.
[35] R. Knight,et al. Quantitative and Qualitative β Diversity Measures Lead to Different Insights into Factors That Structure Microbial Communities , 2007, Applied and Environmental Microbiology.
[36] J. Belperio,et al. Lung transplantation: infection, inflammation, and the microbiome , 2011, Seminars in Immunopathology.
[37] Lior Pachter,et al. Disordered Microbial Communities in Asthmatic Airways , 2010, PloS one.
[38] V. Valentine,et al. Infections in lung allograft recipients: ganciclovir era. , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[39] R. Elashoff,et al. Aspergillus Colonization of the Lung Allograft Is a Risk Factor for Bronchiolitis Obliterans Syndrome , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[40] G. Tian,et al. Dirichlet and Related Distributions: Theory, Methods and Applications , 2011 .
[41] M. Collins,et al. Characterization of some strains from human clinical sources which resemble "Leptotrichia sanguinegens": description of Sneathia sanguinegens sp. nov., gen. nov. , 2001, Systematic and applied microbiology.
[42] W. V. van Son,et al. Association Between Donor MBL Promoter Haplotype and Graft Survival and the Development of BOS After Lung Transplantation , 2008, Transplantation.
[43] P. Corris,et al. Pseudomonas aeruginosa Colonization of the Allograft After Lung Transplantation and the Risk of Bronchiolitis Obliterans Syndrome , 2008, Transplantation.
[44] P. Gajer,et al. Vaginal microbiome of reproductive-age women , 2010, Proceedings of the National Academy of Sciences.
[45] Shu-sen Lin,et al. Assessing oropharyngeal dysphagia after lung transplantation: altered swallowing mechanisms and increased morbidity. , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[46] G. Patterson,et al. Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[47] William A. Walters,et al. QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.
[48] D Heng,et al. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors. , 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[49] J. Maurer. Pseudomonas aeruginosa Colonization of the Allograft After Lung Transplantation and the Risk of Bronchiolitis Obliterans Syndrome , 2009 .
[50] J. Bartlett,et al. Should fiberoptic bronchoscopy aspirates be cultured? , 2015, The American review of respiratory disease.